Title: MMI/Pfizer Course: Molecules to Medicines - How Biopharma Delivers - DAY 1
This MMI/Pfizer Course will be of interest to research students, academic staff and clinicians, whether contemplating a career in industry or doing translational research in academia. It will also be of interest to those already working in a commercial setting with an interest in the biopharmaceutical industry.
The lectures provide an overview of biopharmaceutical discovery, development and manufacturing, delivered by key staff from Pfizer.
Senior Staff from Pfizer (please see at the bottom of this page)
Lecture course Fees (does not include Workshop)
The registration charges do not include accommodation or travel. Please contact email@example.com for further information
Please note that in addition to the lecture course, there is a MMI/Pfizer Molecules to Medicines Workshop usually taking place on the day following the lecture course.
In the first instance this workshop is open to postgraduate students with research experience (e.g. at least one year into their PhD studies). There are a limited number of places available on the workshop. If places are available we will open attendance to postdoctoral staff also.
Comments from participants on a previous run of the Lecture Course:
"This was a thoroughly enjoyable course, well recommended and superbly organized".
"I have already recommended to many people who can be interested".
"Extremely informative and enjoyable two days. Well impressed".
|Wednesday 16 November 2016|
|1005||Introduction to the business of discovering biopharmaceuticals
Dr Matthew Lambert (Pfizer)
|1115||Current biopharmaceutical product candidates and a look into next generation technologies
Dr Brian Fennell (Pfizer)
|MANUFACTURING Brian Hasset (Pfizer)|
|1205||Introduction to the science and technology of biopharmaceutical manufacturing|
|1255||Lunch break (lunch will be provided)|
|1340||Focus on the application of molecular technologies in manufacturing environments|
|DEVELOPMENT Caitriona Crawford (Pfizer)|
|1540||Process Development – Owning the process|
|1630||Discussion & round up|
|Please see abstracts here|
|Back to top|
Dr Brian Fennell (Global Biotherapeutic Technologies, Pfizer)
Brian Hassett (Principal Scientist, Development Analytical Sciences, Pfizer)
Dr Matthew Lambert (Global Biotherapeutic Technologies, Pfizer)
Caitriona Crawford (Global Biotherapeutic Technologies, Pfizer)
The Molecules to Medicines Course and Workshop were originally initiated in 2006 as a collaboration with Wyeth Biopharma. They were first developped and delivered by Dr Davinder Gill (then Assistant Vice President, Biologic Therapeutics, Wyeth Pharmaceuticals, Cambridge, MA, USA), Dr Brendan Hughes (then Director of Development, Wyeth Medica Ireland, Grange Castle) & Dr Mark Leonard (then Director, Gene Expression Technologies, Wyeth BioPharma Campus, Andover, MA, USA).
|Back to top|